Efficacy of disitamab vedotin-based therapy in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis

Urologic Oncology Seminars and Original Investigations 2026

View at publisher

Authors: Jianjun Ye, Wei Li, Mengni Zhang, Xinyang Liao, Qihao Wang, Zeyu Chen, Xiang Tu, Ping Tan, Peng Zhang, Hao Zeng, Yali Shen, Qiang Wei

+1 more

Yige Bao

DOI: 10.1016/j.urolonc.2026.111034

Cited by: 1

References: 45

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Esophageal Cancer Research and Treatment Ferroptosis and cancer prognosis

References 45